Lactoferrin inhibits early steps of human BK polyomavirus infection

Antiviral Research

Volumn 72, Issue 2, 2006, Pages 145-152

  Longhi, Giovanna ^a   Pietropaolo, Valeria ^a   Mischitelli, Monica ^a   Longhi, Catia ^a   Conte, Maria Pia ^a   Marchetti, Magda ^b   Tinari, Antonella ^b   Valenti, Piera ^c   Degener, Anna Marta ^a   Seganti, Lucilla ^a   Superti, Fabiana ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Antiviral agents; BK virus; Lactoferrin

Indexed keywords

GLYCOPROTEIN; IRON BINDING PROTEIN; LACTOFERRIN; TRANSFERRIN;

ADSORPTION; ANIMAL CELL; ARTICLE; BINDING COMPETITION; BK VIRUS; COW; DRUG POTENCY; HUMAN; MILK; NEUTROPHIL; NONHUMAN; POLYMORPHONUCLEAR CELL; POLYOMA VIRUS; PRIORITY JOURNAL; URINARY TRACT INFECTION; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS INHIBITION;

ANIMALS; ANTIVIRAL AGENTS; BK VIRUS; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; DNA, VIRAL; DOSE-RESPONSE RELATIONSHIP, DRUG; LACTOFERRIN; NEUTRALIZATION TESTS; VERO CELLS; VIRUS ATTACHMENT; VIRUS REPLICATION;

BK POLYOMAVIRUS; DNA VIRUSES; MAMMALIA;

EID: 33748320756     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2006.05.008     Document Type: Article

References (65)

1. Abrink M., Larsson E., Gobl A., and Hellman L. Expression of lactoferrin in the kidney: implications for innate immunity and iron metabolism. Kidney Int. 57 (2000) 2004-2010
2. Andersen J.H., Osbakk S.A., Vorland L.H., Traavik T., and Gutteberg T.J. Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts. Antivir. Res. 51 (2001) 141-149
3. Andersen J.H., Jenssen H., and Gutteberg T.J. Lactoferrin and lactoferricin inhibit herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir. Antivir. Res. 58 (2003) 209-215
4. Andersen J.H., Jenssen H., Sandvik K., and Gutteberg T.J. Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface. J. Med. Virol. 74 (2004) 262-271
5. Arao S., Matsuura S., Nonomura M., Miki K., Kabasawa K., and Nakanishi H. Measurement of urinary lactoferrin as a marker of urinary tract infection. J. Clin. Microbiol. 37 (1999) 553-557
6. Arnold D., Di Biase A.M., Marchetti M., Pietrantoni A., Valenti P., Seganti L., and Superti F. Antiadenovirus activity of milk proteins: lactoferrin prevents viral infection. Antivir. Res. 53 (2002) 153-158
7. Chapman C., Flower A.J., and Durrant S.T. The use of vidarabine in the treatment of human polyomavirus associated acute haemorrhagic cystitis. Bone Marrow Transplant. 7 (1991) 481-483
8. Corallini A., Possati L., Trabanelli C., Giraudo E., Rocchetti R., Talevi S., Caputo A., Bussolino F., and Barbanti-Brodano G. Tumor-host interaction mediates the regression of BK virus-induced vascular tumors in mice: involvement of transforming growth factor-beta1. Carcinogenesis 24 (2003) 1435-1444
9. de Bruyn G., and Limaye A.P. BK virus-associated nephropathy in kidney transplant recipients. Rev. Med. Virol. 14 (2004) 193-205
10. Degener A.M., Pietropaolo V., Di Taranto C., Jin L., Ameglio F., Cordiali-Fei P., Trento E., Sinibaldi L., and Orsi N. Identification of a new control region in the genome of the DDP strain of BK virus isolated from PBMC. J. Med. Virol. 58 (1999) 413-419
11. De Mattei M., Martini F., Corallini A., Gerosa M., Scotlandi K., Carinci P., Barbanti-Brodano G., and Tognon M. High incidence of BK virus large-T-antigen-coding sequences in normal human tissues and tumors of different histotypes. Int. J. Cancer 61 (1995) 756-760
12. Di Biase A.M., Pietrantoni A., Tinari A., Siciliano R., Valenti P., Antonini G., Seganti L., and Superti F. Heparin-interacting sites of bovine lactoferrin are involved in anti-adenovirus activity. J. Med. Virol. 69 (2003) 495-502
13. Drobni P., Naslund J., and Evander M. Lactoferrin inhibits human papillomavirus binding and uptake in vitro. Antivir. Res. 64 (2004) 63-68
14. Farasati N.A., Shapiro R., Vats A., and Randhawa P. Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system. Transplantation 79 (2005) 116-118
15. Fioriti D., Videtta M., Mischitelli M., Degener A.M., Russo G., Giordano A., and Pietropaolo V. The human polyomavirus BK: Potential role in cancer. J. Cell Physiol. 204 (2005) 402-406
16. Fujihara T., and Hayashi K. Lactoferrin inhibits herpes simplex virus type-1 (HSV-1) infection in mouse cornea. Arch. Virol. 140 (1995) 1469-1472
17. Gardner S.D., Field A.M., Coleman D.V., and Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1 (1971) 1253-1257
18. Groves M.L. The isolation of a red protein from milk. J. Am. Chem. Soc. 82 (1960) 3345-3350
19. Hara K., Ikeda M., Saito S., Matsumoto S., Numata K., Kato N., Tanaka K., and Sekihara H. Lactoferrin inhibits hepatitis B virus infection in cultured human hepatocytes. Hepatol. Res. 24 (2002) 228-235
20. Harmsen M.C., Swart P.J., de Béthune M.P., Pauwels R., De Clercq E., Thé T.H., and Meijer D.K.F. Antiviral effects of plasma and milk proteins: Lactoferrin shows a potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. J. Infect. Dis. 172 (1995) 380-388
21. Hasegawa K., Motsuchi W., Tanaka S., and Dosako S. Inhibition with lactoferrin of in vitro infection with human herpes virus. Jpn. J. Med. Sci. Biol. 47 (1994) 73-85
22. Haversen L.A., Engberg I., Baltzer L., Dolphin G., Hanson L.A., and Mattsby-Baltzer I. Human lactoferrin and peptides derived from a surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice. Infect. Immun. 68 (2000) 5816-5823
23. Hirsch H.H. BK virus: opportunity makes a pathogen. Clin. Infect. Dis. 41 (2005) 354-360
24. Hirsch H.H., and Steiger J. Polyomavirus BK. Lancet Infect. Dis. 3 (2003) 611-623
25. Hirsch H.H., Brennan D.C., Drachenberg C.B., Ginevri F., Gordon J., Limaye A.P., Mihatsch M.J., Nickeleit V., Ramos E., Randhawa P., Shapiro R., Steiger J., Suthanthiran M., and Trofe J. Polyomavirus-associated nephropathy in renal transplantation: Interdisciplinary analyses and recommendations. Transplantation 79 (2005) 1277-1286
26. Ikeda M., Sugiyama K., Tanaka T., Tanaka K., Sekihara H., Shimotohno K., and Kato N. Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes. Biochem. Biophys. Res. Commun. 245 (1998) 549-553
27. Ikeda M., Nozaki A., Sugiyama K., Tanaka T., Naganuma A., Tanaka K., Sekihara H., Shimotohno K., Saito M., and Kato N. Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells. Virus Res. 66 (2000) 51-63
28. Ishii K., Takamura N., Shinohara M., Wakui N., Shin H., Sumino Y., Ohmoto Y., Teraguchi S., and Yamauchi K. Long-term follow-up of chronic hepatitis C patients treated with oral lactoferrin for 12 months. Hepatol. Res. 25 (2003) 226-233
29. Iwasa M., Kaito M., Ikoma J., Takeo M., Imoto I., Adachi Y., Yamauchi K., Koizumi R., and Teraguchi S. Lactoferrin inhibits hepatitis C virus viremia in chronic hepatitis C patients with high viral loads and HCV genotype 1b. Am. J. Gastroenterol. 97 (2002) 766-767
30. Jeltsch J.M., Hen R., Maroteaux L., Garnier J.M., and Chambon P. Sequence of the chicken ovotransferrin gene. Nucl. Acids Res. 15 (1987) 7643-7645
31. Kaito M. Use of lactoferrin for chronic hepatitis C. Hepatol. Res. 32 (2005) 200-201
32. Knowles W.A., Pipkin P., Andrews N., Vyse A., Minor P., Brown D.W., and Miller E. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J. Med. Virol. 71 (2003) 115-123
33. Lin T.Y., Chu C., and Chiu C.H. Lactoferrin inhibits enterovirus 71 infection of human embryonal rhabdomyosarcoma cells in vitro. J. Infect. Dis. 186 (2002) 1161-1164
34. Linder M.C. Nutrition and metabolism of the trace elements. In: Linder M.C. (Ed). Nutritional Biochemistry and Metabolism. 2nd ed. (1991), Appleton and Lange, Norwalk, CN
35. Marchetti M., Longhi C., Conte M.P., Pisani S., Valenti P., and Seganti L. Lactoferrin inhibits herpes simplex virus type 1 adsorption to Vero cells. Antivir. Res. 29 (1996) 221-231
36. Marchetti M., Pisani S., Antonini G., Valenti P., Seganti L., and Orsi N. Metal complexes of bovine lactoferrin inhibit in vitro replication of herpes simplex virus types 1 and 2. Biometals 11 (1998) 89-94
37. Marchetti M., Superti F., Ammendolia M.G., Rossi P., Valenti P., and Seganti L. Inhibition of poliovirus type 1 infection by iron-, manganese- and zinc-saturated lactoferrin. Med. Microbiol. Immunol. 187 (1999) 199-204
38. Marchetti M., and Superti F. Antiviral activity of lactoferrin. In: Pandalai S.G. (Ed). Recent Developments in Antiviral Research (2001), Transworld Research Network, Trivandrum, India 193-203
39. Marchetti M., Trybala E., Superti F., Johansson M., and Bergstrom T. Inhibition of herpes simplex virus infection by lactoferrin is dependent on interference with the virus binding to glycosaminoglycans. Virology 318 (2004) 405-413
40. McCann K.B., Lee A., Wan J., Roginski H., and Coventry M.J. The effect of bovine lactoferrin and lactoferricin B on the ability of feline calicivirus (a norovirus surrogate) and poliovirus to infect cell cultures. J. Appl. Microbiol. 95 (2003) 1026-1033
41. Metz-Boutigue M.H., Jolles J., Mazurier J., Schoentgen F., Legrand D., Spik G., Montreuil J., and Jolles P. Human lactotransferrin: amino acid sequence and structural comparisons with other transferrins. Eur. J. Biochem. 145 (1984) 659-676
42. Moens U., and Van Ghelue M. Polymorphism in the genome of non-passaged human polyomavirus BK: implications for cell tropism and the pathological role of the virus. Virology 331 (2005) 209-231
43. Moore S.A., Anderson B.F., Groom C.R., Haridas M., and Baker E.N. Three-dimensional structure of diferric bovine lactoferrin at 2.8 Å resolution. J. Mol. Biol. 274 (1997) 222-236
44. Murphy M.E., Kariwa H., Mizutani T., Yoshimatsu K., Arikawa J., and Takashima I. In vitro antiviral activity of lactoferrin and ribavirin upon hantavirus. Arch. Virol. 145 (2000) 1571-1582
45. Phelps C.F., and Antonini E. A study of the kinetics of iron and copper binding to hen ovotransferrin. Biochem. J. 147 (1975) 385-391
46. Pierce A., Colavizza D., Benaissa M., Maes P., Tartar A., Montreuil J., and Spik G. Molecular cloning and sequence analysis of bovine lactotransferrin. Eur. J. Biochem. 196 (1991) 177-184
47. Pietrantoni A., Di Biase A.M., Tinari A., Marchetti M., Valenti P., Seganti L., and Superti F. Bovine lactoferrin inhibits adenovirus infection by interacting with viral structural polypeptides. Antimicrob. Agents Chemother. 47 (2003) 2688-2691
48. Pietropaolo V., Di Taranto C., Degener A.M., Jin L., Sinibaldi L., Baiocchini A., Melis M., and Orsi N. Transplacental transmission of human polyomavirus BK. J. Med. Virol. 56 (1998) 372-376
49. Puddu P., Borghi P., Gessani S., Valenti P., Belardelli F., and Seganti L. Antiviral effect of bovine lactoferrin saturated with metal ions on early steps of human immunodeficiency virus type 1 infection. Int. J. Biochem. Cell Biol. 30 (1998) 1055-1062
50. Roth J.A., and Garrick M.D. Iron interactions and other biological reactions mediating the physiological and toxic actions of manganese. Biochem. Pharmacol. 66 (2003) 1-13
51. Saiki R.K., Scharf S., Faloona F., Mullis K.B., Horn G.T., Erlich H.A., and Arnheim N. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230 (1985) 1350-1354
52. Seganti L., Mastromarino P., Superti F., Sinibaldi L., and Orsi N. Receptors for BK virus on human erythrocytes. Acta Virol. 25 (1981) 177-181
53. Sinibaldi L., Goldoni P., Pietropaolo V., Longhi C., and Orsi N. Involvement of gangliosides in the interaction between BK virus and Vero cells. Arch Virol. 113 (1990) 291-296
54. Sinibaldi L., Goldoni P., Pietropaolo V., Cattani L., Peluso C., and Di Taranto C. Role of phospholipids in BK virus infection and haemagglutination. Microbiologica 15 (1992) 337-344
55. Superti F., Ammendolia M.G., Valenti P., and Seganti L. Antirotaviral activity of milk proteins: lactoferrin prevents rotavirus infection in the enterocyte-like cell line HT-29. Med. Microbiol. Immunol. 186 (1997) 83-91
56. Superti F., Siciliano R., Rega B., Giansanti F., Valenti P., and Antonini G. Involvement of bovine lactoferrin metal saturation, sialic acid and protein fragments in the inhibition of rotavirus infection. Biochim. Biophys. Acta 1528 (2001) 107-115
57. Swart P.J., Kuipers M.E., Smit C., Pauwels R., de Béthune M.P., De Clercq E., Meijer D.K.F., and Huisman J.G. Antiviral effects of milk proteins: acylation results in polyanionic compounds with potent activity against human immunodeficiency virus types 1 and 2 in vitro. AIDS Res. Hum. Retrov. 12 (1996) 769-775
58. Tanaka K., Ikeda M., Nozaki A., Kato N., Tsuda H., Saito S., and Sekihara H. Lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C: a pilot study. Jpn. J. Cancer Res. 90 (1999) 367-371
59. Trofe J., Gordon J., Roy-Chaudhury P., Koralnik I., Atwood W., Eash S., Alloway R.R., Khalili K., Alexander J.W., and Woodle E.S. Basic and clinical research in polyomavirus nephropathy. Exp. Clin. Transplant. 2 (2004) 162-173
60. van der Strate B.W.A., Beljaars L., Molema G., Harmsen M.C., and Meijer D.K.F. Antiviral activities of lactoferrin. Antivir. Res. 52 (2001) 225-239
61. Vorland L.H. Lactoferrin: a multifunctional glycoprotein. APMIS 107 (1999) 971-981
62. White M.K., and Khalili K. Polyomaviruses and human cancer: molecular mechanisms underlying patterns of tumorigenesis. Virology 324 (2004) 1-16
63. Williams J., Elleman T.C., Kingston I.B., Wilkins A.G., and Kuhn K.A. The primary structure of hen ovotransferrin. Eur. J. Biochem. 122 (1982) 297-303
64. Xu B., Chia S.E., and Ong C.N. Concentrations of cadmium, lead, selenium, and zinc in human blood and seminal plasma. Biol. Trace Elem. Res. 40 (1994) 49-57
65. Yi M., Kaneko S., Yu D.Y., and Murakami S. Hepatitis C virus envelope proteins bind lactoferrin. J. Virol. 71 (1997) 5997-6002